Also trades as: OCPNY (OTC) · $vol 7M · OLYMY (OTC) · $vol 1M · OCPNF (OTC) · $vol 0M

¥1,961.00 ($12.41)

+3.00 (+0.15%)

Weekly Expected Move ±3.3%

¥1830 ¥1894 ¥1958 ¥2022 ¥2086

JPX · Healthcare · Medical - Devices · Tech Score Neutral · Power 46 · ¥2.16T mcap · 1.06B float · 0.435% daily turnover

Revenue

$1.01T +1.3% ▲

5Y CAGR: +6.7%

Gross Profit

$654.1B +0.7% ▲

5Y CAGR: +7.3%

Operating Income

$147.0B -21.0% ▼

5Y CAGR: +12.4%

Net Income

$68.2B -42.2% ▼

5Y CAGR: +39.5%

EPS (Diluted)

$61.20 -40.5% ▼

5Y CAGR: +6.4%

EBITDA

$170.5B -26.0% ▼

5Y CAGR: +4.0%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$750.1B	$881.9B	$925.8B	$997.3B	$1.01T
YoY Growth	+2.7%	+17.6%	+5.0%	+7.7%	+1.3%
Cost of Revenue	$297.2B	$285.1B	$342.1B	$348.0B	$356.6B
Gross Profit	$571.7B	$596.8B	$583.6B	$649.3B	$654.1B
Gross Margin	76.2%	67.7%	63.0%	65.1%	64.7%
R&D Expenses	$85.3B	$76.9B	$80.7B	$85.0B	$109.9B
SG&A Expenses	$371.2B	$386.4B	$437.9B	$376.2B	$397.1B
Operating Expenses	$405.4B	$420.5B	$434.3B	$463.2B	$507.1B
Operating Income	$149.4B	$176.3B	$149.3B	$186.0B	$147.0B
Operating Margin	19.9%	20.0%	16.1%	18.7%	14.5%
Interest Expense	$5.1B	$8.2B	$5.8B	$4.8B	$9.3B
Income Before Tax	$141.7B	$182.3B	$43.6B	$159.1B	$94.0B
Tax Expense	$33.9B	$44.3B	$8.9B	$41.3B	$25.8B
Net Income	$115.7B	$143.4B	$242.6B	$117.9B	$68.2B
Net Margin	15.4%	16.3%	26.2%	11.8%	6.7%
EPS (Diluted)	$90.17	$113.08	$199.44	$102.80	$61.20
EBITDA	$210.0B	$254.6B	$112.1B	$252.5B	$170.5B
Shares Outstanding	1.28B	1.27B	1.22B	1.15B	1.11B

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$234.8B	$239.2B	$251.2B	$272.1B	$206.5B	$247.8B	$261.0B	$295.3B
Cost of Revenue	$78.6B	$72.5B	$83.2B	$79.3B	$71.4B	$86.5B	$96.1B	$102.5B
Gross Profit	$156.2B	$166.8B	$168.0B	$192.8B	$135.1B	$161.3B	$164.9B	$192.8B
Gross Margin	66.5%	69.7%	66.9%	70.8%	65.4%	65.1%	63.2%	65.3%
R&D Expenses	$24.0B	$19.2B	$27.0B	$14.8B	$27.9B	$26.7B	$25.9B	$29.5B
SG&A Expenses	$118.8B	$119.1B	$98.1B	$117.9B	$94.3B	$93.2B	$99.8B	$109.9B
Operating Expenses	$128.7B	$123.7B	$125.1B	$132.7B	$122.2B	$119.9B	$125.7B	$139.3B
Operating Income	$27.5B	$43.1B	$42.9B	$60.1B	$12.9B	$41.4B	$39.2B	$53.4B
Operating Margin	11.7%	18.0%	17.1%	22.1%	6.3%	16.7%	15.0%	18.1%
Interest Expense	$2.2B	$1.4B	$2.7B	$544M	$1.2B	$5.3B	$2.3B	$516M
Income Before Tax	$26.4B	$42.4B	$36.4B	$53.9B	$16.9B	$27.9B	$22.1B	$27.1B
Tax Expense	$11.6B	$7.9B	$9.3B	$12.4B	$7.9B	$7.7B	$8.0B	$2.3B
Net Income	$14.6B	$34.4B	$27.4B	$41.5B	$9.0B	$20.2B	$14.2B	$24.8B
Net Margin	6.2%	14.4%	10.9%	15.2%	4.4%	8.1%	5.4%	8.4%
EPS (Diluted)	$12.49	$29.77	$24.19	$36.50	$7.96	$18.05	$12.84	$22.40
EBITDA	$44.8B	$59.7B	$59.0B	$71.6B	$34.3B	$49.9B	$42.2B	$44.1B
Shares Outstanding	1.17B	1.16B	1.13B	1.14B	1.13B	1.12B	1.10B	1.11B

7733.T JPX